AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 15 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 4.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $36,567,000 | -7.5% | 52,100,000 | 0.0% | 1.12% | -3.6% |
| Q4 2018 | $39,530,000 | -11.8% | 52,100,000 | -11.7% | 1.17% | +9.7% |
| Q3 2018 | $44,796,000 | +21.4% | 59,000,000 | +18.3% | 1.06% | +43.2% |
| Q2 2018 | $36,907,000 | -5.1% | 49,875,000 | 0.0% | 0.74% | +18.1% |
| Q1 2018 | $38,903,000 | +7.1% | 49,875,000 | +10.5% | 0.63% | -2.9% |
| Q4 2017 | $36,326,000 | +3.9% | 45,125,000 | +4.6% | 0.65% | +23.9% |
| Q3 2017 | $34,952,000 | +24.4% | 43,150,000 | +23.3% | 0.52% | +24.8% |
| Q2 2017 | $28,088,000 | -0.9% | 35,000,000 | 0.0% | 0.42% | +1.7% |
| Q1 2017 | $28,351,000 | -39.9% | 35,000,000 | -46.6% | 0.41% | -51.0% |
| Q4 2016 | $47,208,000 | +4.4% | 65,567,000 | -3.0% | 0.84% | +17.3% |
| Q3 2016 | $45,228,000 | +23.0% | 67,567,000 | +4.1% | 0.72% | +19.7% |
| Q2 2016 | $36,762,000 | +32.7% | 64,915,000 | +19.1% | 0.60% | +30.3% |
| Q1 2016 | $27,693,000 | -58.7% | 54,500,000 | -46.0% | 0.46% | -11.0% |
| Q4 2015 | $67,040,000 | +111.0% | 101,000,000 | +137.6% | 0.52% | +5.3% |
| Q3 2015 | $31,769,000 | – | 42,500,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 24,200,000 | $17,243,000 | 10.27% |
| Context Capital Management, LLC | 3,910,000 | $2,830,000 | 3.10% |
| Telemetry Investments, L.L.C. | 4,500,000 | $3,206,000 | 1.81% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 65,567,000 | $47,208,000 | 0.84% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,500,000 | $21,579,000,000 | 0.42% |
| K2 PRINCIPAL FUND, L.P. | 6,000 | $4,350,000 | 0.41% |
| Tekla Capital Management LLC | 13,000,000 | $9,263,000 | 0.40% |
| Baker Brothers Advisors | 26,517,000 | $19,103,000 | 0.19% |
| FALCON POINT CAPITAL, LLC | 1,500,000 | $1,069,000 | 0.14% |
| Orbimed Advisors | 8,000,000 | $5,976,000 | 0.08% |